Ads
related to: beta amyloid- Disease Impact
hATTR amyloidosis can progress fast
and lead to significant burden.
- About hATTR Amyloidosis
Read more about this
hereditary disease.
- Dosing and Administration
Find information about dosing and
administration for this treatment.
- Find a Treatment Center
Locate the treatment center
closest to your patient.
- View Mechanism of Action
Watch a video about
the MOA for this treatment.
- Physician Resources
Find educational links, videos, and
downloadable materials.
- Disease Impact
Search results
New Alzheimer's drug slightly slows cognitive decline. Experts say it's not a silver bullet.
Live Science via Yahoo News· 1 year agoillustration depicts amyloid-beta peptides, the building blocks of amyloid-beta plaques, building up...
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – December 12, 2023 – Zacks.com announces the list of stocks...
Eli Lilly's Decade-Long Effort In Alzheimer's Disease Just Failed
Investor's Business Daily· 1 year agoEli Lilly stock and Biogen stock diverged Thursday after Lilly said a decade-long study of an...
Could Alzheimer's Disease Be Eradicated? Here's What We Know — And What We Don't
Woman's World via Yahoo News· 1 year agoYou can hear the excitement in Kiminobu Sugaya’s voice, and you hope that what he is telling you...
Analysis-Eisai's trial success raises hope for Alzheimer's prevention
Reuters via Yahoo News· 2 years agoClear evidence this week that Eisai and Biogen's drug lecanemab slows cognitive decline in early...
Lilly (LLY) Stock Down as FDA Delays Decision on Donanemab
Zacks via Yahoo Finance· 3 months agoEli Lilly and Company’s LLY stock declined 2.3% on Friday after it announced that an FDA decision on...
Does exercise stave off Alzheimer's? Even stretching and balance movements can help, study says
USA TODAY via Yahoo News· 2 years agoFor older adults at risk of dementia, regular exercise from light stretching to rigorous aerobics...
Alzheimer's Stocks Take A Body Blow After Roche's High-Profile Failure
Investor's Business Daily· 2 years agoA highly watched Alzheimer's drug from Roche failed in its final-stage test, but Roche stock rose...
Promising new Alzheimer's drugs may benefit whites more than Blacks
Reuters via AOL· 10 months agoGroundbreaking treatments for Alzheimer's disease that work by removing a toxic protein called beta...
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
Zacks via Yahoo Finance· 1 year agoBiogen Inc. BIIB and partner Eisai announced that the latter submitted a marketing authorization...
Ads
related to: beta amyloid